drugset / Trial / NCT03302156

PSMA PET and MRI in Gynecological Cancers

NCT03302156

Phase 2 Terminated 15 enrolled University of Wisconsin, Madison
Non-randomizedParallel-groupOpen-labelDiagnostic

Summary

The goal of this research is to determine the accuracy of PSMA positron emission tomography (PET) and multi-parametric magnetic resonance (MR) imaging to detect the presence of gynecological cancer cells in the body.

Timeline

Start
2017-11-15
Primary completion
2020-01-20
Completion
2020-01-20

Drugs

EvaluationDrugModalityDoseRoute
Subject 18F-DCFPyL Diagnostic / imaging agent